MedservRegis p.l.c. (MSE: MDS)
Malta
· Delayed Price · Currency is EUR 0.440
-0.010 (-2.22%)
At close: Sep 6, 2024
MedservRegis p.l.c. Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Revenue | 74.16 | 73.93 | 66.94 | 29.92 | 11.29 | 20.88 | Upgrade
|
| Revenue Growth (YoY) | 1.78% | 10.44% | 123.69% | 165.13% | -45.96% | 4.48% | Upgrade
|
| Cost of Revenue | 54.08 | 54.53 | 52.78 | 22.55 | 8.39 | 11.51 | Upgrade
|
| Gross Profit | 20.08 | 19.4 | 14.16 | 7.37 | 2.89 | 9.37 | Upgrade
|
| Selling, General & Admin | 13.43 | 13.21 | 13.07 | 8.9 | 5.59 | 6.79 | Upgrade
|
| Other Operating Expenses | 1.09 | -0.25 | - | - | -0.37 | -0.19 | Upgrade
|
| Operating Expenses | 13.76 | 12.2 | 13.54 | 9.34 | 7.32 | 10.4 | Upgrade
|
| Operating Income | 6.33 | 7.2 | 0.63 | -1.97 | -4.43 | -1.03 | Upgrade
|
| Interest Expense | -3.82 | -4.19 | -4.02 | -2.14 | - | -3.04 | Upgrade
|
| Interest & Investment Income | 1.09 | 1.09 | 0.34 | 0.06 | 0.07 | 3.05 | Upgrade
|
| Earnings From Equity Investments | - | - | - | 0.03 | 0.5 | 0.12 | Upgrade
|
| Currency Exchange Gain (Loss) | -2.76 | -2.76 | 7.3 | 3.96 | -4.91 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.5 | - | - | - | - | -6.17 | Upgrade
|
| EBT Excluding Unusual Items | 0.33 | 1.34 | 4.26 | -0.05 | -8.77 | -7.06 | Upgrade
|
| Impairment of Goodwill | - | - | -0.37 | -1.03 | -2.58 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.44 | 0.44 | -1.11 | 0.31 | 0.16 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.03 | -0.03 | -0.33 | -0.39 | - | - | Upgrade
|
| Asset Writedown | -0.08 | -0.08 | -2.29 | -6.2 | -0.32 | - | Upgrade
|
| Other Unusual Items | - | - | -0.14 | - | - | - | Upgrade
|
| Pretax Income | 0.67 | 1.67 | 0.02 | -7.36 | -11.52 | -7.06 | Upgrade
|
| Income Tax Expense | 0.5 | 0.38 | -0.52 | -0.06 | 0.73 | 0.49 | Upgrade
|
| Earnings From Continuing Operations | 0.17 | 1.29 | 0.54 | -7.3 | -12.26 | -7.56 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | 0.1 | -0.42 | - | Upgrade
|
| Net Income to Company | 0.17 | 1.29 | 0.54 | -7.2 | -12.68 | -7.56 | Upgrade
|
| Minority Interest in Earnings | -0.3 | -0.21 | 0.03 | -0.31 | - | - | Upgrade
|
| Net Income | -0.13 | 1.08 | 0.58 | -7.51 | -12.68 | -7.56 | Upgrade
|
| Net Income to Common | -0.13 | 1.08 | 0.58 | -7.51 | -12.68 | -7.56 | Upgrade
|
| Net Income Growth | - | 87.23% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | - | 102 | 102 | 53 | 112 | - | Upgrade
|
| Shares Outstanding (Diluted) | - | 102 | 102 | 53 | 112 | - | Upgrade
|
| Shares Change (YoY) | - | - | 90.17% | -52.36% | - | - | Upgrade
|
| EPS (Basic) | - | 0.01 | 0.01 | -0.14 | -0.11 | - | Upgrade
|
| EPS (Diluted) | - | 0.01 | 0.01 | -0.14 | -0.11 | - | Upgrade
|
| EPS Growth | - | 87.25% | - | - | - | - | Upgrade
|
| Free Cash Flow | 10.3 | 9.72 | 17.04 | 1.54 | 3.32 | 0.88 | Upgrade
|
| Free Cash Flow Per Share | - | 0.10 | 0.17 | 0.03 | 0.03 | - | Upgrade
|
| Gross Margin | 27.08% | 26.24% | 21.16% | 24.64% | 25.62% | 44.87% | Upgrade
|
| Operating Margin | 8.53% | 9.74% | 0.93% | -6.57% | -39.27% | -4.93% | Upgrade
|
| Profit Margin | -0.17% | 1.46% | 0.86% | -25.10% | -112.31% | -36.19% | Upgrade
|
| Free Cash Flow Margin | 13.88% | 13.15% | 25.45% | 5.14% | 29.43% | 4.21% | Upgrade
|
| EBITDA | 11.83 | 12.78 | 6.66 | 1.83 | -2.73 | 0.9 | Upgrade
|
| EBITDA Margin | 15.95% | 17.28% | 9.94% | 6.12% | -24.18% | 4.29% | Upgrade
|
| D&A For EBITDA | 5.5 | 5.58 | 6.03 | 3.8 | 1.7 | 1.93 | Upgrade
|
| EBIT | 6.33 | 7.2 | 0.63 | -1.97 | -4.43 | -1.03 | Upgrade
|
| EBIT Margin | 8.53% | 9.74% | 0.93% | -6.57% | -39.27% | -4.93% | Upgrade
|
| Effective Tax Rate | 74.41% | 22.58% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.